NDC product
Carbidopa, Levodopa and Entacapone
NDC 0378-8305 · Mylan Pharmaceuticals Inc.
Key facts
| Product NDC | 0378-8305 |
|---|---|
| Proprietary name | Carbidopa, Levodopa and Entacapone |
| Labeler | Mylan Pharmaceuticals Inc. |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA021485 |
| Marketing start | Oct 28, 2013 |
| Marketing end | Jun 30, 2022 |
| Listing certified through | Jun 30, 2022 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: